U.S. Metals and Mining Stock News

Ollie's Bargain Outlet Holdings reported US$679.56 million in second quarter sales and raised its fiscal 2025 full-year earnings guidance in late August 2025, following year-over-year growth in both sales and net income. The company also completed a multi-year share repurchase program totaling over 6.36 million shares for US$436.29 million, reflecting a long-term commitment to returning capital to shareholders. We'll explore how the raised full-year guidance following strong quarterly...

Fortinet (FTNT) just shook the market with new third-quarter guidance that landed below investor expectations. The company’s announcement has already drawn the attention of several law firms, each launching investigations into possible securities law violations amid concern over Fortinet’s revenue outlook and how it communicated shifts in its product growth strategy. For shareholders and potential buyers, this kind of turbulence sets a fresh backdrop for deciding what comes next. Is the...

MSCI (MSCI) just unveiled its Private Credit Factor Model, a new analytics tool aimed squarely at tackling some long-standing frustrations for institutional investors in the surging private credit market. As allocations to private credit continue to rise and the call for transparency grows louder, MSCI’s latest launch is positioned as a meaningful answer. The company’s new solution offers investors a way to break down risks, stress test exposures, and integrate private credit into total...

Conagra Brands (CAG) just rolled out a collaboration that could turn heads for anyone watching the food and snacks space. The company’s Slim Jim brand is teaming up with Buffalo Wild Wings to launch two new chicken stick flavors, an effort clearly aimed at capitalizing on both the surging demand for meat snacks and the loyal fanbase of these household names. This launch is not only about creative product development; it also signals Conagra’s intent to compete more aggressively in the...

Natera (NTRA) just made headlines by announcing the activation of the ARCHER phase III trial for muscle-invasive bladder cancer, a major step forward for its flagship Signatera molecular residual disease (MRD) test. With support from the National Cancer Institute and more than 100 sites participating across the U.S. and Canada, this trial puts Natera’s technology at the forefront of a rapidly evolving therapeutic area. For investors watching the stock, this partnership signals a direct...

General Electric (GE) is making headlines after its aerospace division unveiled a new strategic partnership with BETA Technologies, a well-known player in electric aviation. The agreement, which includes a $300 million equity investment and gives GE the right to add a director to BETA's board, aims to fast-track development of a hybrid electric turbogenerator for advanced air mobility. This move is more than just another industry announcement; it signals GE’s ambition to be at the forefront...

Installed Building Products recently acquired Carolina Precision Fibers, expanding its product offerings and strengthening its presence in environmentally responsible building materials. This acquisition is expected to reinforce IBP’s position in the multifamily and commercial markets, highlighting its commitment to growth and sustainability initiatives. We’ll look at how the addition of innovative insulation materials could influence IBP's growth outlook and investment narrative. The latest...

Helios Technologies (HLIO) just made waves with a double announcement that is likely to catch the eye of investors weighing their next move. The company revealed that Michael Connaway will be stepping in as Chief Financial Officer this October, while Jeremy Evans, previously Corporate Controller, is being promoted to Chief Accounting Officer. Both appointments bring seasoned leaders into critical finance roles. This signals that Helios may be gearing up for its next phase of operational and...

If you've been keeping an eye on Bancorp (TBBK), you might have noticed the latest move in its stock price. This could pique the curiosity of anyone trying to figure out what happens next. There hasn't been a single major event setting the tone, but the share price momentum alone is enough to make investors wonder if we are looking at a turning point or just a temporary blip. Looking at the bigger picture, Bancorp’s stock has notched a 56% gain in the past year, and momentum seems to have...

Kroger (KR) is putting a fresh face on fall this year, literally, and if you are an investor weighing your next move, this product launch may be worth a closer look. The company has just rolled out a full slate of beauty and wellness products in time for the seasonal shift, featuring new exclusive brands and promotional discounts that are catching shoppers’ eyes. The fall lineup is grabbing headlines not just for variety, with earthy makeup palettes, signature scents, and a surge of KBeauty,...

Lazard (NYSE:LAZ) just shook things up by appointing Dmitry Shevelenko, Chief Business Officer of Perplexity, to its Board of Directors. Shevelenko’s background, spanning leadership stints at Uber, LinkedIn, and Meta, points to a boardroom that is getting serious about technology and operational innovation. While executive appointments do not always move the needle overnight, this one hints at intentions beyond tradition, namely, adapting fast to the tech-driven shifts reshaping global...

Mondelez International (MDLZ) is turning heads this September with the launch of SOUR PATCH KIDS Strips, a new take on one of its most beloved brands. Hitting Target shelves first, these ribbon-style candies aim to catch the eye of both devoted fans and curious newcomers. They offer the familiar sour-then-sweet punch in a fresh chewy format. For investors, this product rollout is one to watch, given how innovation can sometimes move the needle for companies in mature markets like...

If you’ve been keeping an eye on Icahn Enterprises (IEP) lately, the subtle moves in the stock might have caught your attention. There hasn’t been a single headline-driving event lighting up the newsfeeds, but that in itself can feel like a signal worth investigating. Sometimes it’s the quiet stretches, when volatility flattens and the updates slow, that investors wonder if the next catalyst is looming or if the quiet just means value lies beneath the surface. Despite the absence of big...

Huron Consulting Group recently reported robust annual revenue growth and expanded operating margins, highlighting its efficient business scaling over the past year. This operational and financial strength illustrates the firm's success in enhancing profitability while adapting to industry challenges and scaling its services. We'll consider how Huron Consulting Group's strong revenue growth and margin expansion could further influence its long-term investment outlook. These 11 companies...

If you’re holding, watching, or even just curious about Okta (OKTA), this week’s run of headlines probably caught your eye. Okta just announced a partnership with Peraton and the U.S. Department of Defense to launch myAuth, a secure authentication platform set to replace DS Logon for millions of government users. Alongside this, the company dropped earnings that surprised some investors. Okta turned a profit for the last six months and raised its guidance for the coming year, signaling...

If you have Under Armour on your radar, you are likely weighing whether now is a good moment to buy, sell, or simply wait things out. The stock has seen better days, but its recent moves tell a nuanced story. Over the past week, shares have inched up by 2.0%, a welcome change of pace considering the longer-term declines. Zoom out and the picture shifts, with losses of 6.2% over the past month, a substantial drop of 37.0% year-to-date, and a staggering 56.5% decline over five years. These...

If you have been tracking F.N.B (FNB), you probably noticed the recent buzz around the company’s leadership news. The Chief Consumer Banking Officer, Barry C. Robinson, is set to retire after 15 years, and Alfred D. Cho, a veteran with over two decades of experience in major financial institutions, will step into the role. Executive transitions in such strategic positions do not happen every day and often get investors wondering whether these changes will steer the company in a new direction...

Qiagen (NYSE:QGEN) is making headlines with the launch and U.S. FDA clearance of its QIAstat-Dx Rise system, a move aimed at reshaping high-throughput molecular diagnostics for hospitals and labs. For investors, it is hard to ignore a product designed to automate testing processes, boost diagnostic speed, and cut down hands-on time. This combination speaks directly to growing demand for efficiency in healthcare settings. The fact that this is Qiagen’s third FDA-cleared syndromic testing...

Deciding what to do with Jacobs Solutions (NYSE:J) stock? You are not alone. In the past week, Jacobs has landed a trio of major infrastructure wins, including a 15-year public works renewal in Centennial, a pivotal design and consulting role for New York’s massive Interborough Express Light Rail Project, and leadership on Denmark’s ambitious Marselis Tunnel. These contracts span continents but share a common thread: locking in long-term revenues and positioning Jacobs as a go-to for major...

Steven Madden recently reported a difficult second quarter, as new tariffs on imported goods contributed to revenues and earnings per share missing analyst expectations. While headwinds from tariffs persisted, the company emphasized smooth progress integrating Kurt Geiger, highlighting its potential as a significant growth driver going forward. We'll explore how near-term margin pressure from tariffs and momentum with Kurt Geiger integration could influence Steven Madden's investment...

If you have been following Quest Diagnostics (DGX) lately, there is a fresh development that could be a game changer for the company. Just this week, Quest Diagnostics introduced an advanced pharmacogenomic laboratory test service, giving providers new tools to tailor drug prescriptions based on each patient’s genetic profile. With the potential to guide safer and more effective treatments across multiple specialties, and a partnership with Coriell Life Sciences that elevates the offering’s...

Keysight Technologies (KEYS) just raised its full-year 2025 earnings outlook, now expecting revenue to land at the top end of its 5% to 7% target range. For investors wondering what sparked the shift, management cites upbeat demand and momentum across its end markets. This guidance hike comes on the heels of several new product launches aimed at high-growth areas like RF, mmWave, and HDMI testing. This reinforces the idea that the company is riding broader industry tailwinds rather than...

If you’re holding Frontline (NYSE:FRO) or considering a position, the latest news cycle probably has your full attention. The company just reported second quarter results showing noticeable drops in both revenue and net income versus last year, at the same time as announcing a new quarterly dividend of $0.36 per share. These are not small updates, and together they set the stage for a very direct shareholder question: are these numbers a warning sign or an opportunity? Zooming out,...

While M/I Homes, Inc. ( NYSE:MHO ) might not have the largest market cap around , it received a lot of attention from a...